Genetic risk markers for nasopharyngeal carcinoma in Portugal: Tumor necrosis factor alpha-308G>A polymorphism

DNA and Cell Biology

Volumn 30, Issue 2, 2011, Pages 99-103

  Sousa, Hugo ^a,b   Breda, Eduardo ^a   Santos, Alexandra M ^a   Catarino, Raquel ^a,b   Pinto, Daniela ^a   Medeiros, Rui ^a,b  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PORTUGAL; PRIORITY JOURNAL; RECESSIVE GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PORTUGAL; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

HUMAN HERPESVIRUS 4;

EID: 79551624285     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1086     Document Type: Article

References (40)

1. Babel, N., Vergopoulos, A., Trappe, R.U., Oertel, S., Hammer, M.H., Karaivanov, S., et al. (2007). Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients. Transplantation 84, 387-391.
2. Beck, A., Pazolt, D., Grabenbauer, G.G., Nicholls, J.M., Herbst, H., Young, L.S., et al. (2001). Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease. J Pathol 194, 145-151.
3. Brinkman, B.M., Zuijdeest, D., Kaijzel, E.L., Breedveld, F.C., and Verweij, C.L. (1995). Relevance of the tumor necrosis factor alpha (TNF alpha)-308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 46, 32-41.
4. Canedo, P., Duraes, C., Pereira, F., Regalo, G., Lunet, N., Barros, H., et al. (2008). Tumor necrosis factor alpha extended haplotypes and risk of gastric carcinoma. Cancer Epidemiol Biomarkers Prev 17, 2416-2420.
5. Cardoso, C.S., Araujo, H.C., Cruz, E., Afonso, A., Mascarenhas, C., Almeida, S., et al. (2006). Haemochromatosis gene (HFE) mutations in viral-associated neoplasia: linkage to cervical cancer. Biochem Biophys Res Commun 341, 232-238.
6. Catarino, R., Pereira, D., Breda, E., Coelho, A., Matos, A., Lopes, C., et al. (2008). Oncogenic virus-associated neoplasia: a role for cyclin D1 genotypes influencing the age of onset of disease? Biochem Biophys Res Commun 370, 118-122.
7. Catarino, R.J., Breda, E., Coelho, V., Pinto, D., Sousa, H., Lopes, C., et al. (2006). Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma. Head Neck 28, 603-608.
8. Coelho, A., Matos, A., Catarino, R., Pinto, D., Sousa, H., Pereira, D., et al. (2007). The influence of chemokine receptor CCR2 genotypes in the route to cervical carcinogenesis. Gynecol Obstet Invest 64, 208-212.
9. Daniel, D., and Wilson, N.S. (2008). Tumor necrosis factor: renaissance as a cancer therapeutic? Curr Cancer Drug Targets 8, 124-131.
10. Dranoff, G. (2004). Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4, 11-22. (Pubitemid 38111131)
11. Duarte, I., Santos, A., Sousa, H., Catarino, R., Pinto, D., Matos, A., et al. (2005). G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun 334, 588-592. (Pubitemid 40982407)
12. Eksteen, J.A., Scott, P.A., Perry, I., and Jankowski, J.A. (2001). Inflammation promotes Barrett's metaplasia and cancer: a unique role for TNFalpha. Eur J Cancer Prev 10, 163-166.
13. Farrell, P.J. (2002). Tumour viruses-could they be an Achilles' heel of cancer? Eur J Cancer 38, 1815-1816.
14. Ho, S.Y., Wang, Y.J., Chen, H.L., Chen, C.H., Chang, C.J., Wang, P.J., et al. (2004). Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the-308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 15, 657-663.
15. Ho, S.Y., Wang, Y.J., Huang, P.C., Tsai, S.T., Chen, C.H., Chen, H.H., et al. (2006). Evaluation of the associations between the single nucleotide polymorphisms of the promoter region of the tumor necrosis factor-alpha gene and nasopharyngeal carcinoma. J Chin Med Assoc 69, 351-357.
16. Hurme, M. (1998). [Is susceptibility to infections in the genes?]. Duodecim 114, 733-734.
17. Kroeger, K.M., Carville, K.S., and Abraham, L.J. (1997). The-308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34, 391-399.
18. Kroeger, K.M., Steer, J.H., Joyce, D.A., and Abraham, L.J. (2000). Effects of stimulus and cell type on the expression of the-308 tumour necrosis factor promoter polymorphism. Cytokine 12, 110-119.
19. Kuppers, R. (2003). B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 3, 801-812.
20. Machado, J.C., Figueiredo, C., Canedo, P., Pharoah, P., Carvalho, R., Nabais, S., et al. (2003). A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125, 364-371.
21. Mullenbach, R., Lagoda, P.J., and Welter, C. (1989). An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet 5, 391.
22. Oliveira, S., Sousa, H., Santos, A.M., Pinto, D., Pinto-Correia, A.L., Fontoura, D., et al. (2008). The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: a study in exfoliated cervical cells. J Med Virol 80, 424-429.
23. Pillai, S., Bikle, D.D., Eessalu, T.E., Aggarwal, B.B., and Elias, P.M. (1989). Binding and biological effects of tumor necrosis factor alpha on cultured human neonatal foreskin keratinocytes. J Clin Invest 83, 816-821.
24. Santos, A.M., Sousa, H., Pinto, D., Portela, C., Pereira, D., Catarino, R., et al. (2006). Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer. Eur J Cancer 42, 958-963.
25. Sousa, H., Santos, A.M., Catarino, R., Pinto, D., Vasconcelos, A., Lopes, C., et al. (2006). Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development. Eur J Cancer Prev 15, 362-366.
26. Sousa, H., Santos, A.M., Pinto, D., and Medeiros, R. (2007). Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int J Mol Med 20, 731-741.
27. Stuber, F., Udalova, I.A., Book, M., Drutskaya, L.N., Kuprash, D.V., Turetskaya, R.L., et al. (1995).-308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 46, 42-50.
28. Tao, J., and Wasik, M.A. (2001). Epstein-Barr virus associated polymorphic lymphoproliferative disorders occurring in nontransplant settings. Lab Invest 81, 429-437.
29. Tsai, M.H., Chen, W.C., and Tsai, F.J. (2002). Correlation of p21 gene codon 31 polymorphism and TNF-alpha gene polymorphism with nasopharyngeal carcinoma. J Clin Lab Anal 16, 146-150.
30. Vousden, K.H., and Farrell, P.J. (1994). Viruses and human cancer. Br Med Bull 50, 560-581.
31. Wang, D., Dubois, R.N., and Richmond, A. (2009). The role of chemokines in intestinal inflammation and cancer. Curr Opin Pharmacol 9, 688-696.
32. Wang, J.M., Deng, X., Gong, W., and Su, S. (1998). Chemokines and their role in tumor growth and metastasis. J Immunol Methods 220, 1-17. (Pubitemid 28527062)
33. Wang, Y., and Armstrong, S.A. (2007). Genome-wide SNP analysis in cancer: leukemia shows the way. Cancer Cell 11, 308-309.
34. Wilson, A.G., di Giovine, F.S., and Duff, G.W. (1995). Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J Inflamm 45, 1-12.
35. Wilson, A.G., and Duff, G.W. (1995). Tumor necrosis factor. Lancet 345, 649.
36. Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O., and Duff, G.W. (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94, 3195-3199.
37. Wu, G.Y., Wang, X.M., Keese, M., Hasenberg, T., and Sturm, J.W. (2008). [Association between tumor necrosis factor alpha gene polymorphism and colorectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 11, 569-571.
38. Wu, M.S., Huang, S.P., Chang, Y.T., Shun, C.T., Chang, M.C., Lin, M.T., et al. (2002). Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J Infect Dis 185, 106-109.
39. Zur Hausen, H. (2001). Oncogenic DNA viruses. Oncogene 20, 7820-7823.
40. Zur Hausen, H. (2009). The search for infectious causes of human cancers: where and why. Virology 392, 1-10.